Original Article
Yoshihisa Urita*, Toshiyasu Watanabe, Tadashi Maeda, Yosuke Sasaki, Kazuo Hike, Hiroshi Muto, Masaki Sanaka,
Nagato Shimada, Hitoshi Nakajima, Motonobu Sugimoto.
Department of General Medicine and Emergency Care, Toho University School of Medicine, Tokyo, Japan.
Background: During esophageal acid clearance, salivation plays an important role in defending the esophageal mucosa. Mosapride, an agent used in chronic, long-term therapy of gastro-esophageal reflux disease (GERD) was regarded as mediating its efficacy through prokinetic properties. Rebamipide is also widely used as an anti-gastritis and anti-ulcer agent in GERD patients with chronic gastritis. The aim of this study is to investigate the effects of rebamipide, mosapride, and risperidone on the salivation induced by pilocarpine. Materials and Methods: The experiments were conducted on 4-week male SD rats (120-150g). The salivation was induced by intraperitoneally administrated pilocarpine and saliva was collected using preweighted small cotton balls inserted into the animal's mouth every 30 min for 180 min. Thirteen minutes before intraperitoneal administration of pilocarpine, rebamipide, mosapride, and risperidone were administered intraduodenally. Control rats were conducted by intraperitoneal administration of saline and intraduodenal administration of 0.5% methylcellulose solution. Rsults: The saliva weight at 0-30 min was significantly (p<0.01) increased after administration of pilocarpine, compared to control rats. An additional administration of mosapride and rebamipide increased the saliva weight at 0-30 min. The total volume of saliva for 150 min after administration of pilocarpine was the highest after preadministration of rebamipide, followed by mosapride, and risperidone. Conclusions: Increase in salivation produced by i.p. pilocarpine was enhanced by preadministration of rebamipide and mosapride. (Urita Y, Watanabe T, Maeda T, Sasaki Y, Hike K, Muto H, Sanaka M, Shimada N, Nakajima H, Sugimoto M. North Am J Med Sci 2009; 1: 121-124).
Keywords: pilocalpine- induced salivation; mosapride; rebamipide.
Correspondence to: Dr. Yoshihisa Urita, MD, PhD, FACG. Department of General Medicine, Toho University School of Medicine, 6-11-1, Omori-Nishi, Ota-Ku, Tokyo 143-8541, Japan. Tel.: (81) 37624151, Fax. (81) 337656518. Email: foo@eb.mbn.or.jp